FDA experts: Ease restrictions on GSK's Avandia

06/6/2013 | CNN · Reuters

Twenty of 26 FDA advisory panel members voted Thursday to relax or remove restrictions on GlaxoSmithKline's diabetes drug Avandia. Several panel members expressed support for additional research into the cardiovascular risks associated with the drug, but some experts said it was unlikely funding would be available.

View Full Article in:

CNN · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ